New and Special Drug
-
Keruibi (Zamerovimab and Mazorelvimab ) – Rabies PEP | HongKong DengYue Medicine
-
Beyfortus (Nirsevimab) – Respiratory Syncytial Virus | HongKong DengYue Medicine
-
Yinuoqing (Efsubaglutide Alfa Injection) – T2DM | HongKong DengYue Medicine
-
Xinermei (Mazdutide) – Obesity Or Overweigh | HongKong DengYue Medicine
-
JAKAVI (Ruxolitinib) – MF/GVHD | HongKong DengYue Medicine
-
Inlyta (Axitinib) – RCC | HongKong DengYue Medicine
-
VUMON (Teniposide) – Antineoplastic Agent | HongKong DengYue Medicine
-
ILUMETRI (Tildrakizumab) – Tlaque Psoriasis | HongKong DengYue Medicine
-
KESIMPTA (Ofatumumab) – Multiple Sclerosis | HongKong DengYue Medicine
-
Aimovig (Erenumab Injection) – Migraine | HongKong DengYue Medicine
-
Takhzyro lanadelumab-flyo injection – Hereditary Angioedema | HongKong DengYue Medicine
-
Hemlibra (Emicizumab) – Hemophilia A | HongKong DengYue Medicine
-
Dongyinghe (Encofosbuvir) – Hepatitis C | HongKong DengYue Medicine
-
Cyramza (Ramucirumab) – NSCLC | HongKong DengYue Medicine
-
Rystiggo (Rozanolixizumab) – gMG | HongKong DengYue Medicine
-
Margenza (Margetuximab) – HER2 | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights